COVID-19 Research
Drug repurposing against key COVID-19 drug targets using advance machine learning-based algorithms
Novel target identification and drug repositioning for COVID-19 based on interaction network, molecular design and machine learning
Aptamer-based rapid diagnostic kit for detection of coronavirus infection (CoVapt)
Development of fluorescent human transmembrane serine protease 2 (TMPRSS2) activity sensor for rapid screening of inhibitors in vitro and in living cells to combat human COVID-19 and other respiratory infections.
Stem cell derived exosome therapy for clinical management of lung damage in critically-ill corona viral pneumonia patients
An automated lung ultrasound workflow for diagnostic assistance in COVID-19 and beyond
Rapid and sensitive detection of novel coronavirus (SARS-CoV-2) using isothermal nucleic acid amplification
Generation of vesicular stomatitis virus pseudotyped with spike protein of SARS-CoV-2 reporter platform under BSL-2 condition for rapid method of identifying antiviral drug targets
Paper-based Plasmonic Aptamer Linked Immobilised Sorbent Assay (pALISA) for screening COVID-19 disease
Epidemiological Features and Geospatial Evaluation of Covid-19: Correlation With Comorbidities and Prognostic Biomarkers Between Sars-Cov-2 and Mycobacterium tuberculosis
Pages
